BR112015026261A8 - Derivados biaromáticos antibacterianos - Google Patents

Derivados biaromáticos antibacterianos

Info

Publication number
BR112015026261A8
BR112015026261A8 BR112015026261A BR112015026261A BR112015026261A8 BR 112015026261 A8 BR112015026261 A8 BR 112015026261A8 BR 112015026261 A BR112015026261 A BR 112015026261A BR 112015026261 A BR112015026261 A BR 112015026261A BR 112015026261 A8 BR112015026261 A8 BR 112015026261A8
Authority
BR
Brazil
Prior art keywords
understood
comprised
hydroxyl
alkoxide
cyano
Prior art date
Application number
BR112015026261A
Other languages
English (en)
Other versions
BR112015026261A2 (pt
Inventor
Cren Sylvaine
Friedli Astrid
Hubschwerlen Christian
Rueedi Georg
Zumbrunn Cornelia
Original Assignee
Actelion Pharmaceuticals Ltd
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd, Idorsia Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of BR112015026261A2 publication Critical patent/BR112015026261A2/pt
Publication of BR112015026261A8 publication Critical patent/BR112015026261A8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

DERIVADOS BIAROMÁTICOS ANTIBACTERIANOS. A invenção refere-se a compostos antibacterianos da fórmula I em que R é compreendido por H, ciano, alcóxido, cianometóxi, cicloalquil-metóxi, hidroxi-alcóxido, alcóxido-alcóxido, alcóxido-carbonil, 2-etóxi-2-oxoetóxi, 2-(metilamino)-2-oxoetóxi, (1-cianociclobutil)-metóxi, 3-hidroxi-pirrolidin-1-il ou 3,4-diidroxil-ciclopentil)metóxi; U1 é compreendido por N ou CR1, U2 é compreendido por N ou CR2, U3 é compreendido por N ou CR3 e U4 é compreendido por N ou CR4, ficando subtendido que na maior parte das vezes três dos U1, U2, U3 e U4 podem ser N ao mesmo tempo; V1 é compreendido por N ou CR5, V2 é compreendido por N ou CR6, V3 é compreendido por N ou CR7 e V4 é compreendido por N ou CH, ficando subtendido que na maioria dois dos V1, V2, V3 e V4 podem ser N ao mesmo tempo; R1 é compreendido por H, ciano, hidroxila ou alcóxido; R2 é compreendido por H, hidroxila ou alcóxido; R3 é compreendido por H, ciano, hidroxila, alcóxido ou carboxamida; R4 é compreendido por H ou alcóxido; R5 é compreendido por H, hidroxila ou halogênio; R6 é compreendido por H, hidroxila ou halogênio; R7 é compreendido por H; a linha pontilhada ----- é compreendido por uma ligação ou está ausente; W é compreendido por CH ou N quando a linha pontilhada ----- é uma ligação, ou W é compreendido por CH2 quando a linha pontilhada ----- estáausente; X é compreendido por CH ou N; e Q é compreendido por O ou S; e seus respectivos sais.
BR112015026261A 2013-04-16 2014-04-15 Derivados biaromáticos antibacterianos BR112015026261A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2013053021 2013-04-16
PCT/IB2014/060724 WO2014170821A1 (en) 2013-04-16 2014-04-15 Antibacterial biaromatic derivatives

Publications (2)

Publication Number Publication Date
BR112015026261A2 BR112015026261A2 (pt) 2017-07-25
BR112015026261A8 true BR112015026261A8 (pt) 2017-12-26

Family

ID=50639826

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015026261A BR112015026261A8 (pt) 2013-04-16 2014-04-15 Derivados biaromáticos antibacterianos

Country Status (21)

Country Link
US (1) US9527867B2 (pt)
EP (1) EP2986607B1 (pt)
JP (1) JP6375365B2 (pt)
KR (1) KR20150143720A (pt)
CN (1) CN105143216B (pt)
AR (1) AR095884A1 (pt)
AU (1) AU2014255326B2 (pt)
BR (1) BR112015026261A8 (pt)
CA (1) CA2907832A1 (pt)
CL (1) CL2015003019A1 (pt)
EA (1) EA029361B1 (pt)
ES (1) ES2640482T3 (pt)
HK (1) HK1221459A1 (pt)
MA (1) MA38588B1 (pt)
MX (1) MX362338B (pt)
PH (1) PH12015502411A1 (pt)
PL (1) PL2986607T3 (pt)
SA (1) SA515361261B1 (pt)
SG (1) SG11201508479RA (pt)
TW (1) TWI631119B (pt)
WO (1) WO2014170821A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104151316B (zh) 2008-10-07 2016-06-15 埃科特莱茵药品有限公司 三环噁唑烷酮抗生素化合物
AR102256A1 (es) * 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
WO2017157885A1 (de) 2016-03-16 2017-09-21 Bayer Cropscience Aktiengesellschaft N-(cyanbenzyl)-6-(cyclopropylcarbonylamino)-4-(phenyl)-pyridin-2-carboxamid-derivate und verwandte verbindungen als pestizide pflanzenschutzmittel
AR108108A1 (es) 2016-04-14 2018-07-18 Idorsia Pharmaceuticals Ltd Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi
GB2550437B (en) * 2016-05-20 2021-06-23 Bugworks Res Inc Heterocyclic compounds useful as anti-bacterial agents and method for production
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
EP3284739A1 (de) 2017-07-19 2018-02-21 Bayer CropScience Aktiengesellschaft Substituierte (het)arylverbindungen als schädlingsbekämpfungsmittel
US11401277B2 (en) 2017-11-29 2022-08-02 Bugworks Research, Inc. Anti-bacterial heterocyclic compounds and their synthesis
BR112021002298A2 (pt) 2018-08-13 2021-05-04 F. Hoffmann-La Roche Ag compostos heterocíclicos como inibidores da monoacilglicerol lipase
JP2022548028A (ja) 2019-09-12 2022-11-16 エフ.ホフマン-ラ ロシュ アーゲー Magl阻害剤としての4,4a,5,7,8,8a-ヘキサピリド[4,3-b][1,4]オキサジン-3-オン化合物
WO2021190727A1 (en) * 2020-03-24 2021-09-30 F. Hoffmann-La Roche Ag Compounds and their use in the treatment of bacterial infection
CN115785718B (zh) * 2022-11-25 2023-08-22 四川大学 一种多基底表面的金属配位抗菌涂层及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297042A1 (de) 1987-06-23 1988-12-28 Ciba-Geigy Ag Substituierte Penem-Verbindungen
DE19802239A1 (de) 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
AU1026901A (en) 1999-10-29 2001-05-08 Syngenta Participations Ag Novel herbicides
US7205321B2 (en) 2001-11-15 2007-04-17 Eli Lilly And Company Peroxisome proliferator activated receptor alpha agonists
AR040335A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
WO2006102674A2 (en) 2005-03-24 2006-09-28 Microbia, Inc. Diphenylheterocycle cholesterol absorption inhibitors
TW200734311A (en) 2005-11-21 2007-09-16 Astrazeneca Ab New compounds
US7998992B2 (en) 2007-03-30 2011-08-16 Institute Of Medicinal Molecular Design, Inc. Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1
CL2008001003A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
KR101541436B1 (ko) 2007-12-20 2015-08-03 파르마 마르 에스.에이. 항암 화합물
JP5349500B2 (ja) 2008-02-20 2013-11-20 アクテリオン ファーマシューティカルズ リミテッド アザトリシクリック抗菌性化合物
AR070458A1 (es) 2008-02-22 2010-04-07 Actelion Pharmaceuticals Ltd Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana.
WO2010015985A1 (en) * 2008-08-04 2010-02-11 Actelion Pharmaceuticals Ltd Tricyclic alkylaminomethyloxazolidinone derivatives
CN104151316B (zh) 2008-10-07 2016-06-15 埃科特莱茵药品有限公司 三环噁唑烷酮抗生素化合物
US20110195949A1 (en) * 2008-10-10 2011-08-11 Actelion Pharmaceuticals Ltd. 2-benzothiophenyl- and 2-naphthyl-oxazolidinones and their azaisostere analogues as antibacterial agents
RU2616609C2 (ru) 2011-11-08 2017-04-18 Актелион Фармасьютиклз Лтд Антибиотические производные 2-оксо-оксазолидин-3, 5-диила

Also Published As

Publication number Publication date
PL2986607T3 (pl) 2017-11-30
KR20150143720A (ko) 2015-12-23
MA38588A1 (fr) 2017-05-31
TW201516043A (zh) 2015-05-01
CN105143216A (zh) 2015-12-09
JP2016516805A (ja) 2016-06-09
CA2907832A1 (en) 2014-10-23
BR112015026261A2 (pt) 2017-07-25
EP2986607A1 (en) 2016-02-24
HK1221459A1 (zh) 2017-06-02
ES2640482T3 (es) 2017-11-03
MA38588B1 (fr) 2018-04-30
WO2014170821A1 (en) 2014-10-23
TWI631119B (zh) 2018-08-01
AU2014255326A1 (en) 2015-11-26
US9527867B2 (en) 2016-12-27
MX362338B (es) 2019-01-11
JP6375365B2 (ja) 2018-08-15
US20160075722A1 (en) 2016-03-17
EA201501025A1 (ru) 2016-08-31
AU2014255326B2 (en) 2018-09-13
CN105143216B (zh) 2018-04-13
CL2015003019A1 (es) 2016-09-30
SA515361261B1 (ar) 2016-06-15
SG11201508479RA (en) 2015-11-27
EA029361B1 (ru) 2018-03-30
AR095884A1 (es) 2015-11-18
PH12015502411A1 (en) 2016-02-22
MX2015014576A (es) 2016-03-04
EP2986607B1 (en) 2017-06-14

Similar Documents

Publication Publication Date Title
BR112015026261A8 (pt) Derivados biaromáticos antibacterianos
CY1120066T1 (el) Ενωση κινολονης
CY1121095T1 (el) Παραγωγα 2,3-dis-yποkataσthmenhς 1-ακυλ-4-αμινο-1,2,3,4-τετραϋδροκινολινης και η χρηση τους ως αναστολεις της περιοχης bromodomain
EA201891742A1 (ru) Замещенное пиперидиновое соединение и его применение
ATE390457T1 (de) In-can stabilisatoren
CU20140105A7 (es) Composición para el control de plagas que incluye un derivado de iminopiridina novedoso
BR112014009302B1 (pt) processo para preparar derivados de quinolina
PE20161343A1 (es) Benzamidas sustituidas para el tratamiento de artropodos
AR094667A1 (es) Piridonamidas como moduladores de canales de sodio
BR112014010713A2 (pt) compostos com atividade nematicida
BR112014013108A2 (pt) compostos tricíclicos fundidos como inibidores da quinase raf
DOP2015000117A (es) Derivados de n-(piridin-2-il)pirimidin-4-amina que contienen un grupo sulfoximina
AR081960A1 (es) Compuestos heterociclicos, su preparacion y su aplicacion terapeutica
PH12016500109A1 (en) Substituted pyrazolylpyrazole derivative and use of same as herbicide
AR097665A1 (es) Trifluorometilpirimidinonas disustituidas y su uso
BR112014009222A2 (pt) processos para a preparação de novos derivados de benzimidazol
BR112015028871A2 (pt) novos compostos de 3,4-dihidro-2h-isoquinolina-1-ona e 2,3-dihidro-isoindol-1-ona
ES2561674T3 (es) Antagonistas de TRPV4
BR112018008885A8 (pt) composto heterocíclico condensado
AR075032A1 (es) Pirazinonas sustituidas
MX368759B (es) Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.
AR097339A1 (es) Derivados de pirazolo[3,4-b]piridin para el tratamiento de trastornos proliferativos
BR112015027760A8 (pt) derivados de imidazo-triazina como inibidores da pde10
TH164069B (th) อนุพันธ์ไบอะโรมาติกต้านแบคทีเรีย
AR094386A1 (es) Derivados de oxazolona antibacterianos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: IDORSIA PHARMACEUTICALS LTD (CH)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: ACTELION PHARMACEUTICALS LTD (CH)

B25C Requirement related to requested transfer of rights

Owner name: ACTELION PHARMACEUTICALS LTD (CH)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: IDORSIA PHARMACEUTICALS LTD (CH)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]